Related Experiment Video
Updated: Dec 30, 2025

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model
Published on: June 4, 2021
Ischemic Stroke with Protein S Deficiency Treated by Apixaban
Ikkei Ohashi1, Shinichi Wada2, Fumitaka Yoshino2
1Division of Cerebrovascular Medicine and Neurology, National Hospitalization Organization, Kyushu Medical Centre, Japan; Department of Neurology, Sapporo Medical University School of Medicine, Japan.
Apixaban effectively prevented ischemic stroke recurrence and reduced deep vein thrombosis in a patient with protein S deficiency, suggesting it as an alternative to warfarin for secondary stroke prevention.
Area of Science:
- Neurology
- Hematology
- Genetics
Background:
- Atherosclerosis obliterans can lead to severe cerebrovascular and venous events.
- Protein S deficiency is a rare inherited thrombophilia increasing the risk of arterial and venous thrombosis.
- Ischemic stroke and deep vein thrombosis (DVT) in young to middle-aged adults warrant thorough etiological investigation.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Peripheral Artery Disease III: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care

